Targeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and Future

Pediatric Non-Hodgkin Lymphomas (NHL) are a diverse group of malignancies and as such treatment can vary based on the different biological characteristics of each malignancy. Significant advancements are being made in the treatment and outcomes of this group of malignancies. This is in large part du...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorge, Caryn E., McDaniel, Jenny K., Xavier, Ana C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932546/
https://www.ncbi.nlm.nih.gov/pubmed/27213405
http://dx.doi.org/10.3390/ph9020028
_version_ 1782441077154775040
author Sorge, Caryn E.
McDaniel, Jenny K.
Xavier, Ana C.
author_facet Sorge, Caryn E.
McDaniel, Jenny K.
Xavier, Ana C.
author_sort Sorge, Caryn E.
collection PubMed
description Pediatric Non-Hodgkin Lymphomas (NHL) are a diverse group of malignancies and as such treatment can vary based on the different biological characteristics of each malignancy. Significant advancements are being made in the treatment and outcomes of this group of malignancies. This is in large part due to novel targeted drug therapies that are being used in combination with traditional chemotherapy. Here, we discuss several new lines of therapy that are being developed or are in current use for pediatric patients with NHL.
format Online
Article
Text
id pubmed-4932546
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-49325462016-07-13 Targeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and Future Sorge, Caryn E. McDaniel, Jenny K. Xavier, Ana C. Pharmaceuticals (Basel) Review Pediatric Non-Hodgkin Lymphomas (NHL) are a diverse group of malignancies and as such treatment can vary based on the different biological characteristics of each malignancy. Significant advancements are being made in the treatment and outcomes of this group of malignancies. This is in large part due to novel targeted drug therapies that are being used in combination with traditional chemotherapy. Here, we discuss several new lines of therapy that are being developed or are in current use for pediatric patients with NHL. MDPI 2016-05-19 /pmc/articles/PMC4932546/ /pubmed/27213405 http://dx.doi.org/10.3390/ph9020028 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Sorge, Caryn E.
McDaniel, Jenny K.
Xavier, Ana C.
Targeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and Future
title Targeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and Future
title_full Targeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and Future
title_fullStr Targeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and Future
title_full_unstemmed Targeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and Future
title_short Targeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and Future
title_sort targeted therapies for the treatment of pediatric non-hodgkin lymphomas: present and future
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932546/
https://www.ncbi.nlm.nih.gov/pubmed/27213405
http://dx.doi.org/10.3390/ph9020028
work_keys_str_mv AT sorgecaryne targetedtherapiesforthetreatmentofpediatricnonhodgkinlymphomaspresentandfuture
AT mcdanieljennyk targetedtherapiesforthetreatmentofpediatricnonhodgkinlymphomaspresentandfuture
AT xavieranac targetedtherapiesforthetreatmentofpediatricnonhodgkinlymphomaspresentandfuture

Ejemplares similares